Suppr超能文献

雪府逐瘀汤对血管生成调控作用的基因芯片分析。

A microarray analysis of angiogenesis modulation effect of Xuefu Zhuyu Decoction on endothelial cells.

机构信息

Experimental Research Center, China Academy of Chinese Medical Sciences, Beijing 100700, China.

出版信息

Chin J Integr Med. 2012 Jul;18(7):502-6. doi: 10.1007/s11655-012-1143-6. Epub 2012 Jul 7.

Abstract

OBJECTIVE

To study the angiogenesis modulation mechanism of Xuefu Zhuyu Decoction () on the endothelial cell line ECV304.

METHODS

ECV304 cells were treated with 2.5% Xuefu Zhuyu Decoction-containing serum (XFZYD-CS) for 24 h, 48 h or 72 h. Thiazolyl blue tetrazolium bromide (MTT), fluorescence activating cell sorter (FACS), migration, adhesion and in vitro tube formation assays were conducted to confirm an angiogenesis effect of XFZYD at 3 time points. An analysis of angiogenesis regulator profiles was performed at 3 times with real-time polymerase chain reaction (RT-PCR) superarray.

RESULTS

At 48 h, XFZYD-CS induced ECV304 significantly improved cell viability, number in S phase, migration, adhesion and tube formation. At 24 h and 72 h, only cell migration was elevated. Microarray results showed that the expression of 27 angiogenesis-related genes was changed.

CONCLUSION

XFZYD-CS treatment induced angiogenesis on ECV304 cells with significant cellcular changes occurring at 48 h and genetic changes as early as 24 h.

摘要

目的

研究血府逐瘀汤()对血管内皮细胞系 ECV304 的血管生成调节机制。

方法

用含 2.5%血府逐瘀汤的血清(XFZYD-CS)处理 ECV304 细胞 24、48 或 72 小时。噻唑蓝溴化四唑(MTT)、荧光激活细胞分选(FACS)、迁移、黏附和体外管形成试验用于在 3 个时间点确认 XFZYD 的血管生成作用。实时聚合酶链反应(RT-PCR)超微阵列用于在 3 个时间点分析血管生成调节剂谱。

结果

48 小时时,XFZYD-CS 诱导 ECV304 细胞活力、S 期细胞数量、迁移、黏附和管形成显著提高。在 24 小时和 72 小时,仅细胞迁移增加。微阵列结果显示 27 个血管生成相关基因的表达发生改变。

结论

XFZYD-CS 处理诱导 ECV304 细胞血管生成,48 小时时出现显著的细胞变化,24 小时时出现早期基因变化。

相似文献

引用本文的文献

本文引用的文献

4
Update on endogenous inhibitors of angiogenesis.血管生成内源性抑制剂的最新进展。
Endothelium. 2006 Mar-Apr;13(2):147-55. doi: 10.1080/1062332060069110.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验